pimozide has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, A; Kim, MJ; Kong, JS; Lee, H; Lee, SS; Park, S; Shim, S | 1 |
| Guo, D; Jiang, Z; Ren, Y; Tang, J; Tao, J | 1 |
2 other study(ies) available for pimozide and Colorectal Neoplasms
| Article | Year |
|---|---|
Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.
Topics: Aged; Animals; beta Catenin; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Disease Progression; Dopamine Antagonists; Female; HCT116 Cells; HT29 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Pimozide; Receptors, Dopamine D2; RNA Interference; Signal Transduction; Survival Rate; Transfection; Tumor Burden; Up-Regulation; Xenograft Model Antitumor Assays; Zinc Finger E-box-Binding Homeobox 1 | 2021 |
Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Dopamine Antagonists; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pimozide; Tumor Cells, Cultured; Wnt Signaling Pathway; Wnt1 Protein; Xenograft Model Antitumor Assays | 2018 |